Michael Dehn - Net Worth and Insider Trading

Michael Dehn Net Worth

The estimated net worth of Michael Dehn is at least $4 Million dollars as of 2024-11-11. Michael Dehn is the Director, Senior Officer of Knight Therapeutics Inc and owns about 759,523 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $4 Million. Michael Dehn is also the Director, Senior Officer of Temas Resources Corp and owns about 495,000 shares of Temas Resources Corp (XCNQ:TMAS) stock worth over $47,025. Details can be seen in Michael Dehn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Dehn has not made any transactions after 2021-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Dehn

To

Michael Dehn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Dehn owns 2 companies in total, including Knight Therapeutics Inc (TSX:GUD) , and Temas Resources Corp (XCNQ:TMAS) .

Click here to see the complete history of Michael Dehn’s form 4 insider trades.

Insider Ownership Summary of Michael Dehn

Ticker Comapny Transaction Date Type of Owner
TSX:GUD Knight Therapeutics Inc 2019-08-12 Director & Senior Officer
XCNQ:TMAS Temas Resources Corp 2021-12-23 Director & Senior Officer

Michael Dehn Latest Holdings Summary

Michael Dehn currently owns a total of 2 stocks. Among these stocks, Michael Dehn owns 759,523 shares of Knight Therapeutics Inc (TSX:GUD) as of August 12, 2019, with a value of $4 Million and a weighting of 98.84%. Michael Dehn also owns 495,000 shares of Temas Resources Corp (XCNQ:TMAS) as of December 23, 2021, with a value of $47,025 and a weighting of 1.16%.

Latest Holdings of Michael Dehn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:GUD Knight Therapeutics Inc 2019-08-12 759,523 5.26 3,995,091
XCNQ:TMAS Temas Resources Corp 2021-12-23 495,000 0.10 47,025

Holding Weightings of Michael Dehn


Michael Dehn Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Dehn has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 12,000 shares on August 12, 2019, which cost Michael Dehn around $93,000.

According to the SEC Form 4 filings, Michael Dehn has made a total of 11 transactions in Temas Resources Corp (XCNQ:TMAS) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Temas Resources Corp is the acquisition of 40,000 shares on December 23, 2021, which cost Michael Dehn around $66,600.

Insider Trading History of Michael Dehn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Dehn Trading Performance

GuruFocus tracks the stock performance after each of Michael Dehn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Dehn is -27.74%. GuruFocus also compares Michael Dehn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Dehn within 3 months outperforms 0 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Dehn's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Dehn

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.17 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -14.91 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael Dehn Ownership Network

Ownership Network List of Michael Dehn

No Data

Ownership Network Relation of Michael Dehn

Insider Network Chart

Michael Dehn Owned Company Details

What does Knight Therapeutics Inc do?

Who are the key executives at Knight Therapeutics Inc?

Michael Dehn is the Director & Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .

Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary

Over the past 18 months, Michael Dehn made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 674,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .

In summary, during the past 3 months, insiders sold 25,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 25,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 929,000 shares were bought by its insiders, resulting in a net purchase of 614,800 shares.

Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Knight Therapeutics Inc Insider Transactions

No Available Data

Michael Dehn Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Dehn. Currently GuruFocus does not have mailing address information for Michael Dehn.